Search
Search titles only
By:
Search titles only
By:
Home
Forums
New posts
Search forums
What's new
New posts
New profile posts
Latest activity
Members
Current visitors
New profile posts
Search profile posts
Log in
Register
Search
Search titles only
By:
Search titles only
By:
New posts
Search forums
Menu
Install the app
Install
Reply to Thread
Guest, we'd love to know what you think about the forum! Take the
Diabetes Forum Survey 2024 »
Home
Forums
Diabetes News and Research
Diabetes News
Once-weekly drug Trulicity released in UK to treat type 2 diabetes
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Message
<blockquote data-quote="DCUK NewsBot" data-source="post: 734403" data-attributes="member: 106455"><p>Trulicity, a once-weekly injectable drug from Eli Lilly for the treatment of type 2 diabetes is now available in the United Kingdom. What is Trulicity? Dulaglutide (Trulicity) is a glucagon-like peptide-1 receptor agonist (GLP-1 RA), designed to improve glycemic control in people with type 2 diabetes. Trulicity can be used as an additional treatment when diet and exercise fail to provide glycemic control, or as a primary therapy when metformin is inappropriate for type 2 diabetes patients with inadequate control. Trulicity works by helping the body release its own insulin, inhibiting the release of glucagon and slowing down digestion after eating to control blood sugar levels. It was launched in the UK on 13 January 2015, and now provides type 2 diabetes patients with an option to Bydureon from AstraZeneca, a modified release exenatide which comes as a once-weekly injection. Treatment reluctance Concerns have been raised by patients about their reluctance to use injectable treatments, with Eli Lilly previously acknowledging this may be viewed as a sign their type 2 diabetes is worsening. "Anxiety about needles is something many GPs and diabetes nurse specialists hear from patients, but options are now available that can help make the injection experience more convenient and less stressful," said Debbie Hicks, nurse consultant in diabetes at Barnet, Enfield and Haringey Mental Health Trust. "In fact, once patients have made the sometimes difficult step to move onto injectable medicines, most people find that the process becomes second nature," Hicks added.</p><p></p><p><strong><a href="http://www.diabetes.co.uk/news/2015/jan/once-weekly-drug-trulicity-released-in-uk-to-treat-type-2-diabetes-96781561.html" target="_blank">Continue reading...</a></strong></p></blockquote><p></p>
[QUOTE="DCUK NewsBot, post: 734403, member: 106455"] Trulicity, a once-weekly injectable drug from Eli Lilly for the treatment of type 2 diabetes is now available in the United Kingdom. What is Trulicity? Dulaglutide (Trulicity) is a glucagon-like peptide-1 receptor agonist (GLP-1 RA), designed to improve glycemic control in people with type 2 diabetes. Trulicity can be used as an additional treatment when diet and exercise fail to provide glycemic control, or as a primary therapy when metformin is inappropriate for type 2 diabetes patients with inadequate control. Trulicity works by helping the body release its own insulin, inhibiting the release of glucagon and slowing down digestion after eating to control blood sugar levels. It was launched in the UK on 13 January 2015, and now provides type 2 diabetes patients with an option to Bydureon from AstraZeneca, a modified release exenatide which comes as a once-weekly injection. Treatment reluctance Concerns have been raised by patients about their reluctance to use injectable treatments, with Eli Lilly previously acknowledging this may be viewed as a sign their type 2 diabetes is worsening. "Anxiety about needles is something many GPs and diabetes nurse specialists hear from patients, but options are now available that can help make the injection experience more convenient and less stressful," said Debbie Hicks, nurse consultant in diabetes at Barnet, Enfield and Haringey Mental Health Trust. "In fact, once patients have made the sometimes difficult step to move onto injectable medicines, most people find that the process becomes second nature," Hicks added. [b][url="http://www.diabetes.co.uk/news/2015/jan/once-weekly-drug-trulicity-released-in-uk-to-treat-type-2-diabetes-96781561.html"]Continue reading...[/url][/b] [/QUOTE]
Verification
Post Reply
Home
Forums
Diabetes News and Research
Diabetes News
Once-weekly drug Trulicity released in UK to treat type 2 diabetes
Top
Bottom
Find support, ask questions and share your experiences. Ad free.
Join the community »
This site uses cookies. By continuing to use this site, you are agreeing to our use of cookies.
Accept
Learn More.…